Michael D. Poisel

Aphton Corp. operates as a biopharmaceutical company, which is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and gastrointestinal disease. The company was founded on May 12, 1981 and is headquartered in Philadelphia, PA.

Founded in 1999 by the late Thomas Watson, Janney Montgomery Scott LLC (JMS) is a full-service financial services firm and registered broker/dealer headquartered in Philadelphia, Pennsylvania. The firm is a subsidiary of Independence Square Properties LLC, itself a subsidiary of Penn Mutual Insurance Co. Their ultimate parent is Harleysville Mutual Insurance Co. JMS is a member of the NYSE, the SIPC and FINRA. The firm provides comprehensive financial advice and services to individual, corporate and institutional investors. Their primary coverage verticals include the consumer, technology, financials and infrastructure sectors.

Footwear Unlimited, Inc. operates as a footwear manufacturer and wholesaler. The company was incorporated in 1966 and is headquartered in Fenton, MO.

Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ.

MixComm, Inc. manufactures semiconductors for transformative wireless solutions. The firm is a fabless semiconductor company developing transformative solutions for emerging wireless applications and markets. The company was founded by Harish Krishnaswamy and Frank Lane in 2017 and is headquartered in Chatham, NJ.

Linnaeus Therapeutics LLC is a development-stage biotech company that identifies and develops small molecule agents for the treatment of various cancers. The private company is based in Philadelphia, PA. The company's compounds can be used to increase or decrease pigmentation and provide a UV-protecting tan without DNA damage. The company was founded in 2016 by Christopher Natale, Todd Ridky, and the CEO is Patrick T. Mooney. The company also focuses on modulating melanocyte pigmentation to correct genetic and acquired skin pigmentation conditions.

Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati.